The company based in Massachusetts(MA)reported a risein revenue to $156.24 milion for the year when compared to $147.79 million in the previous year.
A filing from the company with the Securities and Exchange Commission on Mar 16,2023 showed that its revenue is down 5.71% year-over-year.
The company reported basic earnings per share of $14561.0 and diluted earnings per share of $-1.02.
Anika Therapeutics, Inc. operates in the Surgical & Medical Instruments & Apparatus sector.
Related News
